<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35888154</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Vaccine and Long COVID: A Scoping Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1066</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life12071066</ELocationID><Abstract><AbstractText>As the COVID-19 pandemic progresses, changing definitions and therapeutics regarding the post-acute sequela of COVID-19, particularly long COVID, have become a subject of great interest and study. The study aims to describe the pathophysiology and discuss different therapeutic agents currently available for long COVID. Another objective is to assess comparative efficacy between different types of vaccines on symptoms of long COVID. A preliminary search was conducted using Ovid Medline, Embase, medRxiv, and NIH COVID-19 portfolios. A total of 16 studies were included in our review. Despite some of the data showing variable results, most of the vaccinated patients reported improvement in long COVID symptoms with no significant difference between various types of vaccines. Further trials are needed to better identify the comparative efficacy of vaccines for long COVID and ascertain other therapeutic modalities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mumtaz</LastName><ForeName>Aqsa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Montefiore St. Luke's Cornwall Hospital, Newburgh, NY 12550, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Abdul Ahad Ehsan</ForeName><Initials>AAE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, PA 18505, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Amin Moazzam</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-9521-2265</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Shifa College of Medicine, Islamabad 46000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Subaina Naeem</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-5451-6438</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Shifa College of Medicine, Islamabad 46000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Jehanzaeb</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87102, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasrullah</LastName><ForeName>Adeel</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7604-6978</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Allegheny Health Network, Pittsburgh, PA 15222, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagheer</LastName><ForeName>Shazib</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87102, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Abu Baker</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0003-0503-6961</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87102, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long COVID treatment</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35888154</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pii">life12071066</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. WHO; Geneva, Switzerland: Oct 6, 2021.  [(accessed on 1 May 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold C.G., Monte A.A., Littlefield K., Vest A., Palmer B.E. Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider? Viral Immunol. 2021;34:666&#x2013;668. doi: 10.1089/vim.2021.0126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2021.0126</ArticleId><ArticleId IdType="pmc">PMC8851407</ArticleId><ArticleId IdType="pubmed">34491119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C., Shao W., Chen X., Zhang B., Wang G., Zhang W. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. Int. J. Infect. Dis. 2022;114:252&#x2013;260. doi: 10.1016/j.ijid.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long COVID? Lancet Respir. Med. 2022;10:e30. doi: 10.1016/S2213-2600(22)00020-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00020-0</ArticleId><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun M.C., Singh A.K., Pal D., Das K., Gajjala A., Venkateshan M., Mishra B., Patro B.K., Mohapatra P.R., Subba S.H. Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19. medRxiv. 2022 doi: 10.1101/2022.01.04.21268536. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.04.21268536</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Milne A., Samms E., Stadon L., Maskell N.A., Hamilton F.W. Are vaccines safe in patients with Long COVID? A prospective observational study. medRxiv. 2021 doi: 10.1101/2021.03.11.21253225. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., A Alwan N., Walker A.S. Trajectory of long covid symptoms after covid-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T.A.K., Ashish A., Unsworth A., Martindale J. Are mRNA covid 19 vaccines safe in long covid patients? A health care workers perspective. Br. J. Med. Pract. 2021;14:1.</Citation></Reference><Reference><Citation>Kuodi P., Gorelik Y., Zayyad H., Wertheim O., Wiegler K.B., Jabal K.A., Dror A.A., Nazzal S., Glikman D., Edelstein M. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: A cross-sectional study of patients tested between March 2020 and November 2021. medRxiv. 2022 March 20; doi: 10.1101/2022.01.05.22268800. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Salamun J., Jacquerioz F., Courvoisier D.S., Spechbach H., Guessous I. Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2. J. Gen. Intern. Med. 2022;37:1585&#x2013;1588. doi: 10.1007/s11606-022-07443-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07443-2</ArticleId><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., De Martino M., Palese A., Gerussi V., Bontempo G., Graziano E., Visintini E., D&#x2019;Elia D., Dellai F., Tascini C., et al. Post&#x2013;COVID-19 syn-drome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin. Microbiol. Infect. 2022;23 doi: 10.1016/j.cmi.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="pubmed">35339673</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Pijnenburg L., Chatelus E., Arnaud L., Gottenberg J.E., Sibilia J., Felten R. Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: Results from the nationwide VAXILONG study. Vaccines. 2021;10:46. doi: 10.3390/vaccines10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Senjam S.S., Singh B.Y.P., Parmeshwar K., Nichal N., Manna S., Madan K., Ahmed N.H., Gupta N., Sharma R., Gulleira R., et al. Assessment of Post COVID-19 Health Problems and its Determinants in North India: A descriptive cross section study. medRxiv. 2021 doi: 10.1101/2021.10.03.21264490. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.03.21264490</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain W.D., Sherwood O., Banerjee A., Van der Togt V., Hishmeh L., Rossman J. The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID. Vaccines. 2022;10:652. doi: 10.3390/vaccines10050652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of COVID-19 Vaccination on the Symptoms of Patients with Long COVID: A Target Trial Emulation Using Data from the ComPaRe e-Cohort in France. 2021. [(accessed on 28 June 2022)]. Available online:</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3932953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky J.P., Govindarajulu U., Bagiella E., Goswami R., Kale M., Campbell K.N., Meliambro K., Chen Z., Aberg J.A., Lin J.J. Association of Vaccination with the Persistence of Post-COVID Symptoms. J. Gen. Intern. Med. 2022;37:1748&#x2013;1753. doi: 10.1007/s11606-022-07465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Steves C.J. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, communi-ty-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M.A., Luginbuhl R.D., Parker R. Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines both Before COVID-19 Diagnosis and Up to 12 Weeks After. medRxiv. 2021 doi: 10.1101/2021.11.17.21263608. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumberg Y., Edelstein M., Jabal K.A., Golan R., Perets Y., Saad M., Halabi M. Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: A cross sectional study, Israel, March-December 2021. medRxiv. 2022 December 20; doi: 10.1101/2021.12.30.21268538. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.30.21268538</ArticleId><ArticleId IdType="pmc">PMC9369692</ArticleId><ArticleId IdType="pubmed">35956037</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Felten R., Gallais F., Nazon C., Chatelus E., Pijnenburg L., Sibilia J. Refining &#x201c;Long-COVID&#x201d; by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect. Dis. Ther. 2021;10:1747&#x2013;1763. doi: 10.1007/s40121-021-00484-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I., Hussein A.A.R.M., Amin M.T., Saad M.M., Zayan H.E.E., Abdelsayed M.Z., Moustafa M.M., Ezzat A.R., Helmy R.E.D., Abd_Elaal H.K., et al. Determinants of persistent post-COVID-19 symptoms: Value of a novel COVID-19 symptom score. Egypt. J. Bronchol. 2021;15:10. doi: 10.1186/s43168-020-00049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., TLC Study Group Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., Hastie C., Roderick P., Yao G., Alwan N.A. Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gammazza A.M., L&#xe9;gar&#xe9; S., Bosco G.L., Fucarino A., Angileri F., Oliveri M., Cappello F. Molecular mimicry in the post-COVID-19 signs and symptoms of neurovegetative disorders? Lancet Microbe. 2021;2:e94. doi: 10.1016/S2666-5247(21)00033-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00033-1</ArticleId><ArticleId IdType="pubmed">35544159</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharun K., Singh R., Dhama K. Oxford-AstraZeneca COVID-19 vaccine (AZD1222) is ideal for resource-constrained low-and middle-income countries. Ann. Med. Surg. 2021;65:102264. doi: 10.1016/j.amsu.2021.102264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102264</ArticleId><ArticleId IdType="pmc">PMC8010342</ArticleId><ArticleId IdType="pubmed">33815783</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo K., Mehta A., Mak J., Bishai D., Chansa C., Patenaude B. COVAX and equitable access to COVID-19 vaccines. Bull. World Heal. Organ. 2022;100:315. doi: 10.2471/BLT.21.287516.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.21.287516</ArticleId><ArticleId IdType="pmc">PMC9047429</ArticleId><ArticleId IdType="pubmed">35521037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospi-talized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., et al. Remdesivir for the Treatment of COVID-19&#x2014;Preliminary report. N. Engl. J. Med. 2020;383:1813&#x2013;1826. doi: 10.1056/NEJMoa2007764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb R.L., Vaca C.E., Paredes R., Mera J., Webb B.J., Perez G., Oguchi G., Ryan P., Nielsen B.U., Brown M., et al. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N. Engl. J. Med. 2022;386:305&#x2013;315. doi: 10.1056/NEJMoa2116846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116846</ArticleId><ArticleId IdType="pmc">PMC8757570</ArticleId><ArticleId IdType="pubmed">34937145</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfizer&#x2019;s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study.  [(accessed on 5 November 2021)].  Available online:  https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate#.YrkUqXgDGrU.link.</Citation></Reference><Reference><Citation>Hammond J., Leister-Tebbe H., Gardner A., Abreu P., Bao W., Wisemandle W., Baniecki M., Hendrick V.M., Damle B., Sim&#xf3;n-Campos A., et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with COVID-19. N. Engl. J. Med. 2022;386:1397&#x2013;1408. doi: 10.1056/NEJMoa2118542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar-Debbiny R., Gronich N., Weber G., Khoury J., Amar M., Stein N., Goldstein L.H., Saliba W. Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients. Clin. Infect. Dis. 2022:ciac443. doi: 10.1093/cid/ciac443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac443</ArticleId><ArticleId IdType="pmc">PMC9214014</ArticleId><ArticleId IdType="pubmed">35653428</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K., Strymish J., Stack G., Charness M. Rapid Relapse of Symptomatic SARS-CoV-2 Infection Following Early Suppression with Nirmatrelvir/Ritonavir. Res. Sq. 2022 doi: 10.21203/rs.3.rs-1588371/v1. manuscript in preparation .</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1588371/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran M., Arora M.K., Asdaq S.M.B., Alam Khan S., Alaqel S.I., Alshammari M.K., Alshehri M.M., Alshrari A.S., Ali A.M., Al-Shammeri A.M., et al. Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Molecules. 2021;26:5795. doi: 10.3390/molecules26195795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26195795</ArticleId><ArticleId IdType="pmc">PMC8510125</ArticleId><ArticleId IdType="pubmed">34641339</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Wang Y., Lavrijsen M., Lamers M.M., de Vries A.C., Rottier R.J., Pan Q. SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination. Cell Res. 2022;32:322&#x2013;324. doi: 10.1038/s41422-022-00618-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00618-w</ArticleId><ArticleId IdType="pmc">PMC8771185</ArticleId><ArticleId IdType="pubmed">35058606</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>